Fumaric Acid → HCID 118023976, compound
Reaction equation
[CH3:1][C:2]1([CH3:25])[CH2:7][CH2:6][CH:5]([C:8]2[S:9][C:10]3[N:11]=[C:12]([CH3:24])[N:13]=[C:14]([CH2:17][N:18]4[CH2:22][CH2:21][C@H:20]([OH:23])[CH2:19]4)[C:15]=3[N:16]=2)[CH2:4][CH2:3]1.[C:26]([OH:33])(=[O:32])/[CH:27]=[CH:28]/[C:29]([OH:31])=[O:30]>CCO>[C:26]([OH:33])(=[O:32])/[CH:27]=[CH:28]/[C:29]([OH:31])=[O:30].[CH3:1][C:2]1([CH3:25])[CH2:3][CH2:4][CH:5]([C:8]2[S:9][C:10]3[N:11]=[C:12]([CH3:24])[N:13]=[C:14]([CH2:17][N:18]4[CH2:22][CH2:21][C@H:20]([OH:23])[CH2:19]4)[C:15]=3[N:16]=2)[CH2:6][CH2:7]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
(3S)-1-{[2-(4,4-Dimethylcyclohexyl)-5-methyl[1,3]thiazolo[5,4-d]pyrimidin-7-yl]methyl}pyrrolidin-3-ol (73 mg) was dissolved in EtOH (3 mL), and fumaric acid (24 mg) was added thereto, followed by concentration under reduced pressure. To the residue was added IPE, followed by stirring at room temperature. The precipitate was collected by filtration to obtain (3S)-1-{[2-(4,4-dimethylcyclohexyl)-5-methyl[1,3]thiazolo[5,4-d]pyrimidin-7-yl]methyl}pyrrolidin-3-ol fumarate (81 mg).
Workup
- concentrationfollowed by concentration under reduced pressure
- additionTo the residue was added IPE
- filtrationThe precipitate was collected by filtration
Sources & evidence
- ORD record
- ord-375a9153f76f4be3b79bd71073248e06
- Source dataset
- uspto-grants-2015_06
- Patent number
- US09051339B2
Reaction notes
Loading…